These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 37399288)
1. Association of choroid plexus volume with motor symptoms and dopaminergic degeneration in Parkinson's disease. Jeong SH; Park CJ; Jeong HJ; Sunwoo MK; Ahn SS; Lee SK; Lee PH; Kim YJ; Sohn YH; Chung SJ J Neurol Neurosurg Psychiatry; 2023 Dec; 94(12):1047-1055. PubMed ID: 37399288 [TBL] [Abstract][Full Text] [Related]
2. Lack of association between dopamine transporter loss and non-motor symptoms in patients with Parkinson's disease: a detailed PET analysis of 12 striatal subregions. Park SB; Kwon KY; Lee JY; Im K; Sunwoo JS; Lee KB; Roh H; Ahn MY; Park S; Kim SJ; Oh JS; Kim JS Neurol Sci; 2019 Feb; 40(2):311-317. PubMed ID: 30415448 [TBL] [Abstract][Full Text] [Related]
3. Patterns of striatal dopamine depletion and motor deficits in de novo Parkinson's disease. Jeong SH; Park CW; Lee HS; Kim YJ; Yun M; Lee PH; Sohn YH; Chung SJ J Neural Transm (Vienna); 2023 Jan; 130(1):19-28. PubMed ID: 36462096 [TBL] [Abstract][Full Text] [Related]
4. Presynaptic striatal dopaminergic depletion predicts the later development of freezing of gait in de novo Parkinson's disease: An analysis of the PPMI cohort. Kim R; Lee J; Kim Y; Kim A; Jang M; Kim HJ; Jeon B; Kang UJ; Fahn S Parkinsonism Relat Disord; 2018 Jun; 51():49-54. PubMed ID: 29523394 [TBL] [Abstract][Full Text] [Related]
5. Impaired finger dexterity and nigrostriatal dopamine loss in Parkinson's disease. Lee SH; Lee MJ; Lyoo CH; Cho H; Lee MS J Neural Transm (Vienna); 2018 Sep; 125(9):1333-1339. PubMed ID: 29971496 [TBL] [Abstract][Full Text] [Related]
6. Effect of striatal dopamine depletion on cognition in de novo Parkinson's disease. Chung SJ; Yoo HS; Oh JS; Kim JS; Ye BS; Sohn YH; Lee PH Parkinsonism Relat Disord; 2018 Jun; 51():43-48. PubMed ID: 29526657 [TBL] [Abstract][Full Text] [Related]
7. Early detection of dopaminergic dysfunction and glymphatic system impairment in Parkinson's disease. Yao J; Huang T; Tian Y; Zhao H; Li R; Yin X; Shang S; Chen YC Parkinsonism Relat Disord; 2024 Oct; 127():107089. PubMed ID: 39106761 [TBL] [Abstract][Full Text] [Related]
8. Associations of striatal dopamine transporter binding with motor and non-motor symptoms in early Parkinson's disease. Yang Z; Xie Y; Dou K; Yang L; Xie A Clin Transl Sci; 2023 Jun; 16(6):1021-1038. PubMed ID: 36915231 [TBL] [Abstract][Full Text] [Related]
9. White Matter Hyperintensities, Dopamine Loss, and Motor Deficits in De Novo Parkinson's Disease. Jeong SH; Lee HS; Jung JH; Baik K; Lee YH; Yoo HS; Sohn YH; Chung SJ; Lee PH Mov Disord; 2021 Jun; 36(6):1411-1419. PubMed ID: 33513293 [TBL] [Abstract][Full Text] [Related]
10. Current coffee consumption is associated with decreased striatal dopamine transporter availability in Parkinson's disease patients and healthy controls. Wang C; Zhou C; Guo T; Jiaerken Y; Yang S; Xu X; Hu L; Huang P; Xu X; Zhang M BMC Med; 2023 Jul; 21(1):272. PubMed ID: 37491235 [TBL] [Abstract][Full Text] [Related]
11. An FP-CIT PET comparison of the difference in dopaminergic neuronal loss in subtypes of early Parkinson's disease. Song IU; Chung YA; Oh JK; Chung SW Acta Radiol; 2014 Apr; 55(3):366-71. PubMed ID: 23943629 [TBL] [Abstract][Full Text] [Related]
12. Peripheral Inflammation Is Associated with Dopaminergic Degeneration in Parkinson's Disease. Muñoz-Delgado L; Labrador-Espinosa MÁ; Macías-García D; Jesús S; Benítez Zamora B; Fernández-Rodríguez P; Adarmes-Gómez AD; Reina Castillo MI; Castro-Labrador S; Silva-Rodríguez J; Carrillo F; García Solís D; Grothe MJ; Mir P Mov Disord; 2023 May; 38(5):755-763. PubMed ID: 36912400 [TBL] [Abstract][Full Text] [Related]
13. Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients. Erro R; Pappatà S; Amboni M; Vicidomini C; Longo K; Santangelo G; Picillo M; Vitale C; Moccia M; Giordano F; Brunetti A; Pellecchia MT; Salvatore M; Barone P Parkinsonism Relat Disord; 2012 Nov; 18(9):1034-8. PubMed ID: 22789824 [TBL] [Abstract][Full Text] [Related]
15. Presynaptic dopamine depletion determines the timing of levodopa-induced dyskinesia onset in Parkinson's disease. Yoo HS; Chung SJ; Chung SJ; Moon H; Oh JS; Kim JS; Hong JY; Ye BS; Sohn YH; Lee PH Eur J Nucl Med Mol Imaging; 2018 Mar; 45(3):423-431. PubMed ID: 29075830 [TBL] [Abstract][Full Text] [Related]
16. Effects of statins on dopamine loss and prognosis in Parkinson's disease. Jeong SH; Lee HS; Chung SJ; Yoo HS; Jung JH; Baik K; Lee YH; Sohn YH; Lee PH Brain; 2021 Nov; 144(10):3191-3200. PubMed ID: 34347020 [TBL] [Abstract][Full Text] [Related]
17. The pattern of FP-CIT PET in pure white matter hyperintensities-related vascular parkinsonism. Lee YH; Lee S; Chung SJ; Yoo HS; Jung JH; Baik K; Ye BS; Sohn YH; Yun M; Lee PH Parkinsonism Relat Disord; 2021 Jan; 82():1-6. PubMed ID: 33220520 [TBL] [Abstract][Full Text] [Related]
18. Association between choroid plexus volume and cognition in Parkinson disease. Jeong SH; Jeong HJ; Sunwoo MK; Ahn SS; Lee SK; Lee PH; Kim YJ; Sohn YH; Park CJ; Chung SJ Eur J Neurol; 2023 Oct; 30(10):3114-3123. PubMed ID: 37498202 [TBL] [Abstract][Full Text] [Related]
19. Cognitive performance correlates with the degree of dopaminergic degeneration in the associative part of the striatum in non-demented Parkinson's patients. Kübler D; Schroll H; Buchert R; Kühn AA J Neural Transm (Vienna); 2017 Sep; 124(9):1073-1081. PubMed ID: 28643101 [TBL] [Abstract][Full Text] [Related]
20. Striatal dopamine transporter uptake, parkinsonism and cognition in Alzheimer's disease. Kang S; Jeon S; Lee YG; Ye BS Eur J Neurol; 2023 Oct; 30(10):3105-3113. PubMed ID: 37493955 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]